The FDA approved Bildyos and Bilprevda are providing new options comparable to Prolia and Xgeva for osteoporosis, cancer-related bone disease, and other skeletal conditions.
A paradigm shift from osseointegration to a more holistic assessment of implant success has placed an emphasis on biologically driven treatment approaches, accentuating optimal tissue regeneration, esthetic outcomes, and long-term peri-implant health.
Discover the evolving landscape of dental education and the critical balance between technology and tradition in teaching dental students' essential skills, as shared by Robert C. Margeas in Inside Dentistry.
A recent study found that the PocketPerio web application improved periodontal diagnosis accuracy for dental students, potentially revolutionizing dental education and clinical practice.